Springtails, fly testes and the secrets of strange reproduction

2022-11-30T10:34:27+00:0030 November 2022|

Dr Kamil Jaron is interested in strange reproduction (in a genomic sense). His work is exploring the changes in DNA variation and chromosome structure caused by the different ways species reproduce, to see how this drives evolution.

An ancient foe and a modern arms race

2022-11-17T17:08:35+00:0017 November 2022|

How genomic surveillance is helping to spot, track and predict drug resistance in malaria parasites across the globe.

Understand, predict, engineer

2022-11-03T12:56:59+00:003 November 2022|

Ben Lehner joins the Sanger Institute as a new Senior Group Leader. He seeks to lay the foundations for programmable biology.

How do you sequence over 240,000 whole human genomes?

2022-09-29T10:48:57+01:0026 September 2022|

The world’s largest human genome sequencing project has been for UK Biobank – a large-scale biomedical database. Sanger staff have sequenced 243,633 human genomes in 3.5 years.

Our UK Biobank Journey: 3 years and over 240,000 human genomes

2022-10-19T09:27:20+01:0026 September 2022|

In 2019, the Sanger Institute started on the most ambitious human genome sequencing project in the world. Three years later, the Institute has delivered nearly 250,000 whole human genome sequences and over 20 petabytes (PB) of data, for the UK Biobank project, to aid research into health and disease.

Finishing genome puzzles

2022-08-10T14:58:13+01:009 August 2022|

Explore the skilful art of interpreting genome sequence data - from the human genome project to all species.

Unlocking surface proteins

2022-08-03T15:30:44+01:003 August 2022|

A decades-long interest in cell surface proteins has led to discoveries as diverse as how malaria parasites invade human blood cells, a vaccine target for a neglected tropical disease, and finding the molecules that must interact to initiate new life.

Breath of fresh air

2022-06-30T22:25:50+01:0030 June 2022|

Dr Josie Bryant is a new group leader at the Sanger Institute. She is interested in how microbes in the human lung evolve and adapt over time and how this affects health and disease. We spoke to Josie about the inspirations behind her science, returning to Sanger, and what excites her about establishing a new research group.